Daejeon, South Korea

Ingyu Hwang


Average Co-Inventor Count = 16.3

ph-index = 4

Forward Citations = 112(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ingyu Hwang: Innovator in Health Science

Introduction

Ingyu Hwang is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of health science, particularly through his innovative research and patents. With a total of four patents to his name, Hwang's work focuses on the therapeutic applications of natural compounds.

Latest Patents

Hwang's latest patents include the use of naringin and naringenin as inhibitors of acyl CoA-cholesterol-o-acyltransferase. This method aims to inhibit the activity of acyl CoA-cholesterol-o-acyltransferase, thereby preventing the accumulation of macrophage-lipid complexes on arterial endothelium and treating hepatic diseases in mammals. Additionally, he has developed a method for inhibiting the activity of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase in mammals, which also involves administering naringin or naringenin.

Career Highlights

Hwang is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential impact on health and disease management.

Collaborations

Some of his notable coworkers include Song-Hae Bok and Kwang-Hee Son, who have collaborated with him on various research projects.

Conclusion

Ingyu Hwang's innovative research and patents highlight his commitment to advancing health science through natural compounds. His contributions are paving the way for new therapeutic approaches in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…